The purpose of this article is to describe the efficiency of selective and competitive inhibitor of dipeptidyl peptidase-4 saxagliptin and saxagliptin/metformin extended-release (XR) fixed-dose combination. This article presents results of the assessment of cardiovascular

Multifactorial approach underlies the bottom of modern management of type 2 diabetes. Currently special attention to glycemic excursion severity is given as the factor that leads to diabetes mellitus prognosis impairment. In the article continuous glucose monitoring systems

Sulfonylureas take a central place in the pharmacotherapy of diabetes mellitus type 2 for many years. The main purpose of this article is to highlight the current scientific data about gliclazide. Gliclazide is sulfonylurea drug with unique properties, which distinguish it

Types 1 and 2 diabetes are on the rise worldwide. Although the treatment of hyperglycemia has benefited from recent advances, aggressive efforts tomaintain euglycemiamay be fraught with risk, especially in older subjects or in subjects vulnerable to hypoglycemic unawareness.

Metabolic effects glucagon-like peptide-1 receptor agonists (GLP-1 RA) are the result of glucose-stimulated insulin secretion enhancement, inhibition of glucagon secretion, slowing gastric emptying and increased satiety. These properties indicate that GLP-1 RA may be

Diabetes mellitus targets sensory neurons during the development of peripheral neuropathy. While polyneuropathy is often routinely considered as another ‘microvascular’ complication of diabetes mellitus, this concept may no longer address the complexities and

The article considers with questions of etiology, pathogenesis, clinic and treatment of the hypothyrosis.

In article results of application of Reduxine®Met (sibutramin+metformine) or metformin at patients with diabetes mellitus type 2 in a disease debut according to endocrinological office of policlinic of Regional clinical hospital No. 3 of Chelyabinsk are analysed.